Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Gaviscon is generally considered compatible with Mounjaro. Because tirzepatide slows gastric emptying, reflux and indigestion are among the most common complaints people notice in the early weeks of treatment — and reaching for an antacid like Gaviscon is a natural first response. That said, there is one practical timing point worth understanding before you do. Mounjaro (tirzepatide) is a prescription-only medicine, and any decision about managing its side effects alongside other remedies should be discussed with the prescriber who oversees your treatment. The information below explains the mechanism, the timing, and when a prescriber's input matters most.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and one of its effects is slowing the rate at which the stomach empties into the small intestine. That slower emptying is part of why people feel full for longer, which is useful for weight management. It also means stomach contents, including acid, sit in the stomach for an extended period. For some people that's fine. For others, especially in the first few weeks or after moving to a higher dose, it translates to nausea, burping, reflux, or a feeling of persistent indigestion. These effects are well-documented in the tirzepatide trials and acknowledged by the NHS medicines page for tirzepatide. They tend to be most pronounced shortly after a dose increase and often settle within one to two weeks as the body adjusts. Knowing the cause matters because it changes what actually helps: eating smaller meals, avoiding lying down soon after eating, and not rushing food all address the underlying dynamic in a way that an antacid alone cannot fully replicate.
A common misconception is that the nausea means the medicine is harming you. It usually doesn't. It's the stomach-slowing effect doing exactly what it's supposed to do, your system is just calibrating. That understanding can take some of the anxiety out of those early weeks.
Gaviscon's active ingredients (typically sodium alginate and sodium bicarbonate in the liquid form, or similar alginates in the tablet) form a floating raft on top of stomach contents, creating a physical barrier against reflux rather than reducing acid production. Because it acts locally in the stomach rather than being absorbed into the bloodstream, it does not interact with tirzepatide's pharmacological pathway. For most people, that means using Gaviscon for occasional heartburn or reflux while on Mounjaro is reasonable.
Timing, though, deserves a moment's thought. Because tirzepatide slows gastric emptying, any medicine or remedy you take orally will also pass through the stomach more slowly than usual. For Gaviscon this is unlikely to cause harm, it's designed to sit in the stomach. But it's a useful reminder that your digestive system is operating differently on treatment, and spacing out anything you take (particularly other oral medicines) is sensible. If you take other prescription medicines alongside Mounjaro, that conversation belongs with your prescriber or GP. For people wondering about other aspects of life on treatment, our guide to what you can take alongside Mounjaro covers a broader range of questions.
Occasional heartburn managed with an over-the-counter antacid is one thing. A few situations call for a more formal conversation. First, if reflux or indigestion is happening daily and disrupting meals or sleep, that's worth flagging, a prescriber can adjust the titration pace, advise on dietary changes, or consider whether a longer-term acid-suppressing medicine is appropriate. Second, and more urgently, severe or persistent stomach pain that spreads towards the back, with or without vomiting, should be assessed by a doctor promptly. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as an infrequent but serious side effect, the symptom pattern is distinct from ordinary reflux, but it's important not to brush off significant abdominal pain. Gaviscon won't address pancreatitis, and no antacid is a substitute for clinical assessment when the pain is severe.
For context on who is suited to tirzepatide treatment and what the assessment covers, the eligibility criteria for Mounjaro page is a good starting point. If you're already on treatment and managing a minor symptom like occasional reflux, you're doing the right thing by checking, and Gaviscon used sensibly is a reasonable short-term tool in most cases. For anything beyond the occasional, reach out to the people overseeing your treatment. At nume, our clinical team provides priority aftercare seven days a week, so there's always someone to ask.
If you're thinking about starting treatment and want to understand the costs involved, our Mounjaro pricing page sets out what's included transparently. And if you'd like to explore your options more broadly, our weight-loss treatment overview explains how the different medicines compare. People also often ask about practical day-to-day considerations, such as whether it's safe to take Mounjaro on your period, and our guides on travelling with Mounjaro on a plane and what to know before taking Mounjaro on a flight cover those questions in detail. When you're ready to have your situation reviewed by a real prescriber, speak to our prescribers through a free consultation, same-day clinical review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.